Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.9%

2 terminated out of 34 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

15%

5 trials in Phase 3/4

Results Transparency

36%

5 of 14 completed with results

Key Signals

5 with results88% success

Data Visualizations

Phase Distribution

19Total
Not Applicable (9)
P 1 (1)
P 2 (4)
P 4 (5)

Trial Status

Completed14
Unknown9
Recruiting4
Terminated2
Withdrawn2
Not Yet Recruiting1

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (34)

Showing 20 of 20 trials
NCT03244020Phase 4Enrolling By Invitation

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

NCT05290857Not ApplicableRecruiting

Anticoagulation After GI Bleeding Pilot Study and Registry

NCT04997265Not ApplicableCompleted

Strategies for Anticoagulation During Venovenous ECMO

NCT04263038Phase 4Recruiting

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

NCT06887270Not ApplicableNot Yet RecruitingPrimary

Peri-procedural Management of Direct Oral Anticoagulants for Central VENOus Catheters in CAncer Patients With Venous Thromboembolism or Atrial Fibrillation Pilot Study

NCT03186729Phase 4Terminated

Study of Antithrombotic Treatment After IntraCerebral Haemorrhage

NCT06795698Phase 2Completed

The Effect of Prophylactic Anticoagulation on Major Bleeding Events in Hospitalized Chronic Kidney Disease and Lower Limb Fracture Patients.

NCT05801068Not ApplicableActive Not Recruiting

Perioperative Management of Factor Xa Inhibitors

NCT04046952Not ApplicableTerminated

Comparing TR Band to Statseal in Conjunction With TR Band II

NCT06627933Recruiting

Optimization of Management in Patients With Cardiovascular Disease After Lower Limb Joint Replacement

NCT06232278Unknown

Long-term Results of Percutaneous Left Atrial Closure at Brest University Hospital (CLAPOT)

NCT05563714Not ApplicableCompleted

Anticoagulation With Enhanced Gastrointestinal Safety

NCT04662515Completed

NOACs in Oral and Maxillofacial Surgery: Impact on Post-operative Complications

NCT06194617Recruiting

Rivaroxaban in Elderly Chinese Venous Thromboembolism Patients

NCT06168838UnknownPrimary

Anticoagulant-associated Intracranial Hemorrhage

NCT03803579Completed

Baseline Concentration of Direct Oral Anticoagulant and Incidence of Adverse Event Measure And See (MAS)

NCT05804734Completed

Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments in Hemophilia

NCT03772613Phase 2Completed

The Randomized OPTIMAL-ACT Trial

NCT04002011Phase 2WithdrawnPrimary

DOAC Versus VKA After Cardiac Surgery

NCT03209258Not ApplicableCompleted

The Third, Intensive Care Bundle With Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial

Scroll to load more

Research Network

Activity Timeline